secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagenic Therapeutics, Inc.new (PTIX)
CIK:        0001022899
Form:       8-K
Filed at:   2026-03-03T23:59:59+00:00
Accession:  0001493152-26-008605
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Protagenic Therapeutics appoints William Nichols as President; base salary $350k, 40% bonus target, 1% option grant
--------------------------------------------------------------------------------

- William (Bill) Nichols, Jr., age 51, appointed President effective Feb 3, 2026.
- Prior senior commercial leadership roles at bluebird bio, Dova Pharmaceuticals, and Bristol-Myers Squibb.
- Annual base salary $350,000; eligible for annual target bonus of 40% of base salary.
- Employment agreement includes option grant equal to ~1.0% of fully diluted share count.
- No family relationships or transactions requiring Item 404(a) disclosure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022899/000149315226008605/0001493152-26-008605-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022899/000149315226008605/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-008605

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer